alphaveZUARI₹222.50

Zuari Agro Chemicals Limited

Annual Quarterly₹ CrorePeersMADRASFERT SPIC ARIES KHAICHEM RAMAPHOMcap ₹936 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	1,649.0	843.4	897.7	1,096.7	1,123.3	1,264.1	952.0	1,246.1	1,422.6	343.7	187.3	615.2
Other Income	23.1	12.4	126.8	9.9	16.7	5.9	21.8	6.2	4.7	1.2	8.2	0.7
Total Income	1,672.1	855.9	1,024.5	1,106.6	1,140.0	1,270.0	973.8	1,252.2	1,427.4	344.9	195.6	615.9
Expenses
+ Cost of Materials Consumed	558.9	393.4	464.1	528.8	404.8	558.0	416.5	472.0	606.0	6.5	6.8	37.8
+ Purchases of Stock-in-Trade	112.0	122.0	78.2	187.9	291.0	245.5	266.7	328.6	343.3	226.7	201.9	441.6
+ Changes in Inventories	500.7	-13.2	36.3	-57.6	27.7	-25.7	-77.6	9.0	-32.0	48.7	-59.0	4.0
+ Employee Benefit Expense	31.5	31.8	34.8	35.7	35.6	33.6	33.5	39.7	37.1	18.2	16.8	21.6
+ Finance Costs	55.0	48.8	51.0	48.3	44.0	39.9	36.1	34.4	32.0	18.0	17.1	17.8
+ Depreciation & Amortisation	23.3	24.2	24.5	25.2	24.9	26.2	25.2	24.5	25.2	4.2	4.8	4.9
+ Other Expenses	307.0	234.2	265.8	283.7	263.2	336.2	280.5	256.0	294.4	34.2	35.2	51.1
Total Expenses	1,588.4	841.2	954.6	1,052.0	1,091.0	1,213.7	980.9	1,164.2	1,306.0	356.6	223.6	578.7
EBITDA	138.8	75.2	18.6	118.2	101.2	116.5	32.5	140.7	173.8	9.3	-14.4	59.2
EBIT	115.5	51.0	-5.9	92.9	76.3	90.4	7.3	116.2	148.6	5.1	-19.2	54.2
Profit
PBT before Exceptional Items	83.7	14.7	69.9	54.6	49.0	56.3	-7.1	88.1	121.3	-11.7	-28.1	37.2
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	817.5	-2.9	-2.8	0.0
Pretax Income	83.7	14.7	69.9	54.6	49.0	56.3	-7.1	88.1	938.8	-14.6	-30.9	37.2
+ Current Tax	19.2	8.3	2.4	16.0	19.6	22.7	5.8	26.4	31.7	16.0	1.2	15.0
+ Deferred Tax	19.8	8.6	-5.5	10.9	0.4	-2.6	-0.6	0.6	167.9	-26.0	-1.1	-0.3
Tax Expense	39.0	16.9	-3.2	26.8	20.0	20.1	5.3	26.9	199.6	-10.0	0.1	14.7
+ Share of Associates & JVs	22.0	30.8	4.3	1.7	64.5	44.7	39.5	66.2	101.1	44.4	5.9	96.2
Net Income	66.6	28.6	77.4	29.4	93.4	81.0	27.2	127.4	840.4	39.7	-25.1	118.7
+ Net Income — Continuing Ops	44.6	-2.3	73.1	27.7	28.9	36.3	-12.3	61.2	739.2	-4.7	-31.0	22.5
+ Other Comprehensive Income	0.4	-0.4	8.8	0.8	-1.4	-0.2	4.1	0.1	-0.2	-175.8	-279.9	161.7
Total Comprehensive Income	67.0	28.2	86.2	30.1	92.0	80.8	31.3	127.5	840.2	-136.1	-305.0	280.4
Net Income to Common	—	13.4	75.2	9.2	80.2	54.5	19.8	99.0	805.9	39.7	-25.0	118.5
Minority Interest	—	15.1	2.2	20.2	11.8	26.4	7.4	28.4	34.3	0.0	-0.1	0.2
Per Share
Basic EPS	15.83	6.78	17.87	2.17	19.30	12.97	4.72	23.54	191.68	9.43	-5.94	28.17
Diluted EPS	15.83	6.78	17.87	2.17	19.30	12.97	4.72	23.54	191.68	9.43	-5.94	28.17
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	4.1	0.1	-0.2	-175.8	-279.9	161.7
+ Items NOT to be Reclassified to P&L	0.4	—	—	0.9	-1.8	-0.1	3.8	0.1	-0.1	-205.1	-316.7	188.6
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.3	-0.0	0.1	-29.3	-36.8	27.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.4	-8.8	0.2	-0.4	0.1	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	35.8	-0.3	84.1	9.8	-1.0	-0.1	4.3	0.1	-0.3	-136.1	-279.9	161.7
Comprehensive Income — Non-controlling Interests	31.2	-0.0	2.1	20.4	-0.4	-0.1	-0.2	-0.0	0.1	0.0	0.0	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	15.83	6.78	17.87	2.17	19.30	12.97	4.72	23.54	191.68	9.43	-5.94	28.17
Diluted EPS — Continuing Operations	15.83	6.78	17.87	2.17	19.30	12.97	4.72	23.54	191.68	9.43	-5.94	28.17
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	477.3	341.2	319.1	437.6	399.9	486.4	346.5	436.4	505.3	61.7	37.6	131.9
Gross Margin %	28.95	40.45	35.55	39.90	35.60	38.47	36.39	35.03	35.52	17.96	20.09	21.43
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	83.7	14.7	69.9	54.6	49.0	56.3	-7.1	88.1	121.3	-11.7	-28.1	37.2
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	817.5	-2.9	-2.8	0.0
Net Income Adj (tax-effected)	66.6	28.6	77.4	29.4	93.4	81.0	27.2	127.4	196.7	40.9	-22.3	118.7
EPS Adj	15.83	6.78	17.87	2.17	19.30	12.97	4.72	23.54	44.86	9.71	-5.28	28.17
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	42.1	42.1	42.1	42.1	42.1	42.1	42.1	42.1	42.1	42.1	42.1	42.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.